Welocalize Life Sciences is an industry leader with proven translation and localization proficiency required for global clinical trials, pharmaceuticals, biotech companies, medical devices and healthcare brands.
Welocalize Life Sciences
241 East 4th St., Suite 207
Telephone: 001 301 668 0330
Gary LeBlanc, VP, Regulated and Asia Sales - email@example.com
Erin Wynn, Chief Customer Officer - firstname.lastname@example.org
Nicole Sheehan, MBA, Senior Client Services Director - email@example.com
Recognized leaders in language solutions for life sciences companies.
Welocalize Life Sciences is an industry leader with proven translation and localization proficiency required for global clinical trials, pharmaceuticals, biotech companies, medical devices, healthcare brands, medical providers and government agencies. Our solutions include industry expert localization and translation services for regulatory and compliance content, document translation, linguistic validation, interpreting, website and marketing localization, eLearning and multimedia services.
Welocalize Life Sciences is uniquely qualified to support all of the multilingual initiatives for highly regulated industries. Our objective is to ensure that the language services we provide are accurate and submission ready, ensuring the most rapid time to market for products while mitigating risk.
Established in 1997, Welocalize is headquartered in Frederick, Maryland with 21 global offices and provides language solutions in 175 languages. Welocalize is ISO 9001:2015 and ISO 17100 certified.
Areas of Specialisation:
- Clinical Trial Protocols
- Patient-Reported Outcomes (PROs)
- Quality of Life (QoL) Measures
- Patient Recruitment Materials
- Product Manuals and Labeling
- Packaging and Inserts
- Pharmacological Studies
- Linguistic Validation Studies
Key Practice Areas:
Global Clinical Trials
Clinical research is undergoing the same globalization process as other industries. Clinical trials continue to shift to emerging markets for cost savings, to increase patient recruitment and achieve shorter time-to-market. Welocalize Life Sciences provides professional translation and cross-cultural adaptation of patient-reported outcomes (PROs) into 100 world languages for use in global clinical studies. Our linguistic validation processes allow for your study data to be pooled and compared regardless of where in the world your clinical trials are performed.
Coordinating dozens of linguistic validation projects annually, our team is comprised of professionals with expertise in a variety of therapeutic areas, including: cardiology, endocrinology, genetics, immunology, infectious diseases, oncology, pulmonary and rheumatology.
Patient Reported Outcomes (PROs) and other measurements translated by Welocalize have been used to capture self-reported data ranging from patient diaries to health-related quality of life (HRQL) questionnaires to complex clinical assessments such as psychological evaluations. We ensure that your instruments are compliant with regulatory requirements and are easily understood in all countries.
Our professional medical translators ensure instruments are culturally relevant and acceptable to the target population within each country. In addition, Welocalize ensures language versions are conceptually equivalent to the original instrument and to one another.
Translation is required at many stages in the course of bringing a drug to market, including clinical research, regulatory submissions, manufacturing, marketing and packaging. Translation has many roles in the drug-to-market process and can impact the length of the time to market, regulatory approvals, and the marketing. The obligation to translate clinical trial related documents varies from country to country. In the United States, for example, all documentation for all participants and investigators must be in the local language.
The leading global pharmaceutical companies, medical device manufacturers and biomedical firms turn to Welocalize Life Sciences. We have a track record of successfully supporting multinational clinical trials in every major therapeutic area. Whether translating Patient Reported Outcomes (PROs) for FDA submission or clinical trial protocols, pharmaceutical companies cannot afford to compromise language accuracy or quality.
Professional Medical Translation and Interpreting Services
Welocalize has a proven track record of successfully supporting multinational clinical trials in every major therapeutic area. We have an experienced team of translators, interpreters and editors with impeccable linguistic skills, technical writing expertise, and professional degrees such as MDs and PhDs in all major areas of life sciences and medicine. Our professional, native speaker and accredited linguists translate medical documents to and from more than 175 global languages including Arabic, Chinese, French, German, Italian, Japanese, Korean, Portuguese, Russian, Spanish and Urdu.
Association Memberships and Accreditation:
- ISO 17100 & ISO 9001:2015 Certified
- Drug Information Association
- Globalization and Localization Association
- CSA 7th Largest Global Language Services Provider 2016
- American Translators Association
- Translators Without Borders
Gary LeBlanc has two decades of experience building and leading global teams, while developing and executing successful business growth strategies. At Welocalize, he partners with businesses and law firms to create translation and language technology solutions, while overseeing business development for regulated industries, including legal and life sciences.
Erin Wynn is the champion of the Welocalize customers, ensuring we support our client’s globalization journey. She exemplifies and defines best practices in our Customer First approach across the entire organization. Prior to taking on the CCO role, she was the General Manager for Park IP Translations, a Welocalize company.
Nicole Sheehan plays a leading role in regulatory focused production operations at Welocalize. She is currently the head of global production and client services for patent and legal translations at Park IP Translations, a Welocalize company, and supports life sciences operations under the regulatory umbrella.